MyAverix Finance
US · Real Estate
Compass Biotechnologies Inc (BNGI)
Real Estate Services
Compass Biotechnologies Inc (BNGI) is listed on US in the Real Estate sector. Industry: Real Estate Services. As of 2026-03-30, reported market cap is $14,278, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BNGI
Compass Biotechnologies Inc (BNGI) — FAQ
What is Compass Biotechnologies Inc's market cap?
Compass Biotechnologies Inc (BNGI) has a reported market cap of $14,278 (data as of 2026-03-30).
What is BNGI's P/E ratio?
The price-to-earnings (P/E) ratio for Compass Biotechnologies Inc (BNGI) is 18.00 (data as of 2026-03-30).
Does Compass Biotechnologies Inc pay a dividend?
Dividend yield is not available in the current snapshot for Compass Biotechnologies Inc (BNGI). Check the MyAverix Finance app for the latest dividend data.
What sector is Compass Biotechnologies Inc in?
Compass Biotechnologies Inc (BNGI) is classified in the Real Estate sector (Real Estate Services industry).
What exchange is BNGI listed on?
BNGI is listed on US.
What is Compass Biotechnologies Inc's net margin?
Compass Biotechnologies Inc (BNGI) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.